Enesi Pharma partners with US BARDA on new flu vaccines

Enesi Pharma will leverage its ImplaVax needle-free device and formulation technology for developing new influenza vaccines. Credit: NIH 3D Print Exchange, National Institutes of Health.



  • Enesi Pharma partners with US BARDA on new flu vaccines